Design, synthesis, and antiviral properties of 4′-substituted ribonucleosides as inhibitors of hepatitis C virus replication: The discovery of R1479
David B. Smith(Roche (United States)), Joseph A. Martin(Roche (United States)), Klaus Klumpp(Roche (United States)), Stewart Baker(Roche (United Kingdom)), Peter Blomgren(Roche (United States)), René Devos(Roche (United Kingdom)), Caroline Granycome(Roche (United States)), Julie Q. Hang(Roche (United States)), Christopher Hobbs(Roche (United Kingdom)), Wen-Rong Jiang(Roche (United Kingdom)), Carl Laxton(Roche (United Kingdom)), Sophie Le Pogam(Roche (United States)), Vincent Lévêque(Roche (United States)), Han Ma(Roche (United States)), G. Maile(Roche (United Kingdom)), John H. Merrett(Roche (United Kingdom)), A. Pichota(Roche (United States)), Keshab Sarma(Roche (United States)), Mark A. Smith(Roche (United States)), Steven Swallow(Roche (United States)), Julian Symons(Roche (United States)), D. Vesey(Roche (United Kingdom)), Isabel Nájera(Roche (United Kingdom)), Nick Cammack(Roche (United States))
Cited by 97
Abstract
Related Papers
Inhibition of Hepatitis C Virus RNA Replication by 2′-Modified Nucleoside Analogs
Steven S. Carroll, Joanne E. Tomassini, Michele Bosserman et al.|Journal of Biological Chemistry|2003|337